Frontlight ResearchEarly access
CompletedNo phase
A Study Using Breath Tests to Identify Patients at Risk for Gestational Diabetes
Key facts
- Who runs it
- Kaplan Medical Center
- Where
- Israel1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 18 Dec 2020
- Ended
- 20 Jun 2024
- Type of study
- Observational
- Treatments tested
- Noninvasive Breath Test in Order to Identify Patients at Risk for Developing Gestational Diabetes
- Record updated
- 16 January 2026
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Pregnant women
- ages 18 to 45 years old
- A singleton pregnancy
- Confirmed gestational age by a documented first-trimester ultrasound
Who cannot take part
- Patients diagnosed with gestational or pre-gestational diabetes
- Patients with conditions or medications that affect glucose metabolism
- Patients below the age of 18 or above 45 years-old
- Patients with multiple pregnancies or fetuses with congenital and/or chromosomal anomalies
- Patients after a multifetal pregnancy reduction (spontaneous or iatrogenic)
- Patients not having a sonographic dating during the first trimester of pregnancy
- Patients who will refuse to consent, or are not fit or able to read, understand, or sign an informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of our study is to evaluate the feasibility, and diagnostic value of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.
Treatments tested
- Noninvasive Breath Test in Order to Identify Patients at Risk for Developing Gestational Diabetes
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Pilot Study Evaluating the Use of a Novel Noninvasive Breath Test to Identify Patients at Risk for Developing Gestational Diabetes
- Record updated
- 16 January 2026